Literature DB >> 14511141

The course of some bone remodelling plasma metabolites in healthy horses and in horses offered a calcium-deficient diet.

V de Behr1, D Daron, A Gabriel, B Remy, I Dufrasne, D Serteyn, L Istasse.   

Abstract

An inquiry was carried out to assess the concentrations of plasma metabolites related to bone remodelling in 21 saddle horses of Warmblood breed aged 4-26 years, five draught horses of Ardennes breed aged 4-10 years, and 10 Ardennes foals aged 9-11 months. They were fed according to normal feeding practice in Belgium. The changes in some bone remodelling plasma metabolite concentrations were studied when an unbalanced diet was offered and later corrected for four Warmblood horses. Bone formation was evaluated by bone alkaline phosphatase (BALP), total alkaline phosphatase (TALP) and osteocalcin (bone gla-protein, OC). Bone resorption was assessed by hydroxyproline (HYP). Total calcium, ionized calcium, phosphorus (P) and 25-hydroxyvitamin D3 [25-(OH)D] concentrations were more or less constant. The comparison of four bone remodelling factors between the Ardennes and Warmblood horses showed higher concentrations in the Ardennes breed. Bone marker concentrations decreased according to age. The correction of the unbalanced Ca : P diet induced inconsistent effects at plasma level. The interpretation of the different bone parameters appeared to be difficult if not associated with other parameters such as a complete anamnesis and clinical examination of the animal in addition to dietary evaluation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511141     DOI: 10.1046/j.1439-0396.2003.00428.x

Source DB:  PubMed          Journal:  J Anim Physiol Anim Nutr (Berl)        ISSN: 0931-2439            Impact factor:   2.130


  1 in total

1.  Urinary calcium and oxalate excretion in healthy adult cats are not affected by increasing dietary levels of bone meal in a canned diet.

Authors:  Nadine Passlack; Jürgen Zentek
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.